Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc (GSK) covers the period ending November 2012. The report details a specific share repurchase transaction executed on November 2, 2012, in accordance with shareholder authority granted at the Annual General Meeting on May 3, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on capital structure and share repurchase activity.
- Shares Purchased: 1,500,000 Ordinary Shares of 25 pence each.
- Purchase Price Range: Highest price paid was 1,379.0 pence per share; lowest price paid was 1,348.5 pence per share.
- Treasury Holdings (Settled): 518,290,427 shares, representing 9.52% of total issued share capital.
- Treasury Holdings (Including Unsettled): 522,290,427 shares, representing 10.60% of current total voting rights.
- Shares in Issue (Excluding Treasury): 4,927,118,500 shares.
Material Changes
The primary material change reported is the reduction of outstanding shares through the purchase of 1,500,000 shares on November 2, 2012. Consequently, the percentage of shares held in Treasury increased to 9.52% of issued capital (or 10.60% of voting rights including unsettled shares). The filing does not provide comparative data for prior periods regarding these specific metrics.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on operational outlook, or discussion of risks and contingencies. It explicitly states that the announcement does not constitute an offer or solicitation to purchase securities and is made in conformity with the Financial Services Authority's Disclosure and Transparency Rules.
Investor Verification Checklist
- Verify the total number of shares held in Treasury (518,290,427 settled) against the company's latest annual report.
- Confirm the calculation of voting rights (10.60%) including unsettled shares for disclosure threshold assessments.
- Check the remaining authorization for share buybacks under the mandate granted on May 3, 2012.
- Review the Financial Services Authority's Disclosure and Transparency Rules to ensure compliance with notification requirements based on the 4,927,118,500 shares in issue.